Biotech · Private company · Los Angeles, CA, US
Partillion Bioscience Corporation
Track this companyFree. Adds Partillion Bioscience Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- Multiplexed analysis of antibody secreting cells for enhanced function first antibody discoveryFiscal year 2026 · $306.9KNIH RePORTER 1R43AI186929-01A1 · fetched Nov 12, 2026
- Nanovial Kits for Large-Scale Cell-Cell Interaction SequencingFiscal year 2026 · $979.1KNIH RePORTER 1R44GM165220-01 · fetched Nov 12, 2026
- Scaling function-first antibody discovery leveraging memory B cellsFiscal year 2026 · $1MNIH RePORTER 5R44AI193415-02 · fetched Nov 12, 2026
- Scaling function-first antibody discovery leveraging memory B cellsFiscal year 2025 · $1MNIH RePORTER 1R44AI193415-01 · fetched Nov 12, 2026
- Linking antibody sequences to function at the single-cell level using nanovial technologyFiscal year 2024 · $731.6KNIH RePORTER 5R44GM144000-03 · fetched Nov 12, 2026
- Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector functionFiscal year 2024 · $741.9KNIH RePORTER 5R44GM149102-02 · fetched Nov 12, 2026